Lead Animal Health Industry With Us
We Aspire to be the Leader in the Biopharmaceutical Animal Health Industry Globally
BAV at a glance
BIO-ANGLE VACS SDN BHD (BAV) is a Malaysian company established in 2013 specializing in the global development, manufacturing, and distribution of biotechnology based products, veterinary pharmaceutical and health supplements. It holds a unique position as the sole company globally dedicated to this field. BAV collaborates with renowned institutions like Universiti Putra Malaysia (UPM) and the Malaysian Genome and Vaccine Institute (MGVI) to advance livestock health and disease prevention.
For now, BAV has secured few on-going business deals with our local current clients whereas the international business deals shall be closed upon the completion of our proposed GMP facilities. BAV also has some potential clients in the pipeline who are keen to purchase our products.
BAV has already signed sale and purchase agreements with 5 overseas companies to market 270,000 bottles of STVac to China, Nigeria, Kenya, Indonesia, Republic of Chad and Republic of Uganda with discussions underway for other markets. The market value of animal vaccines in the world is estimated at around USD 12 billion. The total population of goats worldwide is 2.2 billion. BAV is only targeting 25 million goats equivalent to 1% of the total population which has the potential to generate an income of USD 200 million per year.
Our Credo ‘Innovative Vaccine for the Future’, entitles BAV to join the super league of unicorn companies by year 2026. Our mission is to shape the future by shifting the delivery method of the vaccination process by improving the quality, safety and the efficacy of the product. BAV’s continuous R&D program will ensure that it will constantly be the 1st in innovation and development of premium product that is friendly to the user and environment.